BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang Z, Li C, Zhao Z, Liu Z, Guan X, Yang M, Li X, Yuan D, Qiu S, Wang X. Abnormal Liver Function Induced by Space-Occupying Lesions Is Associated with Unfavorable Oncologic Outcome in Patients with Colorectal Cancer Liver Metastases. Biomed Res Int 2018;2018:9321270. [PMID: 29862297 DOI: 10.1155/2018/9321270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Vasilogianni AM, Al-Majdoub ZM, Achour B, Peters SA, Rostami-Hodjegan A, Barber J. Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects. Br J Clin Pharmacol 2021. [PMID: 34599518 DOI: 10.1111/bcp.15098] [Reference Citation Analysis]
2 Ludwig JM, Haubold J, Bauer S, Richly H, Siveke JT, Wimmer J, Umutlu L, Schaarschmidt BM, Theysohn JM. Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion. Radiol Oncol 2021;55:347-53. [PMID: 34051707 DOI: 10.2478/raon-2021-0027] [Reference Citation Analysis]
3 Vasilogianni AM, Achour B, Scotcher D, Peters SA, Al-Majdoub ZM, Barber J, Rostami-Hodjegan A. Hepatic Scaling Factors for In Vitro-In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver Metastasis. Drug Metab Dispos 2021;49:563-71. [PMID: 33980603 DOI: 10.1124/dmd.121.000359] [Reference Citation Analysis]